Blinded Enalapril Comp-Ena+


Combined with:

Aliskiren
Blinded Aliskiren Ali+Tab+CF
Blinded NO Treatment Received Nomed
Comparator Enalapril

Indications and Reactions:

Role Indications Reactions
Primary
Cardiac Failure Chronic 87.5%
Cardiac Failure 6.3%
Palpitations 6.3%
Colonic Polyp 25.0%
Loss Of Consciousness 25.0%
Oedema Peripheral 25.0%
Supraventricular Tachycardia 25.0%
Secondary
Cardiac Failure 79.9%
Cardiac Failure Chronic 4.1%
Cardiac Failure Congestive 3.9%
Diabetes Mellitus 3.1%
Hyperuricaemia 1.3%
Hypertension 1.2%
Atrial Fibrillation 1.1%
Myocardial Infarction 1.0%
Dyslipidaemia 0.8%
Hyperlipidaemia 0.7%
Angina Pectoris 0.6%
Back Pain 0.5%
Gastrooesophageal Reflux Disease 0.5%
Anticoagulant Therapy 0.2%
Blood Calcium Decreased 0.2%
Chronic Obstructive Pulmonary Disease 0.2%
Congestive Cardiomyopathy 0.2%
Constipation 0.2%
Depression 0.2%
Gastritis 0.2%
Renal Impairment 8.9%
Ventricular Dysfunction 8.9%
Ventricular Extrasystoles 8.1%
Vertigo 8.1%
Dyspnoea 7.3%
Vomiting 6.5%
Ventricular Tachycardia 5.7%
Pulmonary Oedema 4.9%
Scar 4.9%
Weight Increased 4.9%
Renal Failure 4.1%
Tachycardia 4.1%
Disease Progression 3.3%
Hyperkalaemia 3.3%
Orthopnoea 3.3%
Urinary Incontinence 3.3%
Urine Output Decreased 3.3%
Cardiac Pacemaker Insertion 2.4%
Left Ventricular Failure 2.4%
Myocardial Infarction 2.4%

Drug Data